Modular Medical (NASDAQ:MODD) Upgraded by Wall Street Zen to “Sell” Rating

Wall Street Zen upgraded shares of Modular Medical (NASDAQ:MODD) from a strong sell rating to a sell rating in a research note published on Sunday.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Modular Medical in a research note on Wednesday, June 24th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.

Modular Medical Price Performance

NASDAQ:MODD opened at $3.54 on Friday. The company has a market cap of $28.85 million, a P/E ratio of -0.41 and a beta of 0.37. The stock’s fifty day moving average price is $3.43 and its two-hundred day moving average price is $5.53. Modular Medical has a 1 year low of $1.72 and a 1 year high of $30.00.

Modular Medical (NASDAQ:MODD) last posted its quarterly earnings results on Friday, August 14th. The company reported ($1.19) EPS for the quarter.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. AWM Investment Company Inc. grew its position in shares of Modular Medical by 20.3% during the 2nd quarter. AWM Investment Company Inc. now owns 441,095 shares of the company’s stock valued at $1,985,000 after purchasing an additional 74,429 shares in the last quarter. 683 Capital Management LLC increased its holdings in shares of Modular Medical by 79.4% in the fourth quarter. 683 Capital Management LLC now owns 1,762,103 shares of the company’s stock worth $642,000 after purchasing an additional 780,000 shares during the period. Bleichroeder LP raised its position in shares of Modular Medical by 41.9% in the fourth quarter. Bleichroeder LP now owns 2,859,581 shares of the company’s stock worth $1,041,000 after buying an additional 845,000 shares in the last quarter. Jane Street Group LLC raised its position in shares of Modular Medical by 446.8% in the fourth quarter. Jane Street Group LLC now owns 163,952 shares of the company’s stock worth $60,000 after buying an additional 133,969 shares in the last quarter. Finally, Perritt Capital Management Inc raised its position in shares of Modular Medical by 34.2% in the third quarter. Perritt Capital Management Inc now owns 85,000 shares of the company’s stock worth $59,000 after buying an additional 21,675 shares in the last quarter. 27.47% of the stock is owned by institutional investors.

Modular Medical Company Profile

Modular Medical, Inc operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.